Tuesday, October 25, 2016

Merck Profit Rises on Cancer Drugs, Vaccines

Merck posted increases in revenue and profit as a closely watched cancer treatment and vaccines bolstered results.

from WSJ.com: US Business http://ift.tt/2dSgA2Y
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)